Everything You Need to Know About the Sinovac Vaccine
The Sinovac vaccine, CoronaVac, is an inactivated vaccine developed by a private Chinese company. It requires two doses given 2-4 weeks apart, similar to mRNA vaccines and most adenovector vaccines. Currently, the Sinovac vaccine is approved in China and for emergency use in other countries.
New York City COVID-19 Vaccine Eligibility
Pfizer-BioNTech, Moderna, and Johnson & Johnson have all received emergency use authorization from the FDA for the use of their Covid-19 vaccines. New York is following a phased distribution of the Covid-19 vaccine. This means that only people identified as eligible in the current phases will be able to receive the vaccine. Currently, only those in Phase 1A and Phase 1B are eligible to receive the vaccine.